2026年 議程

Cambridge VIP主辦第三屆

Bio-IT World Venture, Innovation & Partnering

Connect Capital and Science to Shape the Future
連結資本與科學，塑造未來

2026年5月19日

 

第三屆 Bio-IT World Venture, Innovation & Partnering Conference（2026年5月19日）將作為第25屆 Bio-IT World Conference & Expo的一環，提供推動下一代生物技術和精準醫療的投資者、企業領導者和企業家提供一個高階平台。這場小規模活動將邀集來自創投、私募股權、企業創投部門、成長階段公司和製藥公司的最高管理階層領導者齊聚於此。2026 年議程節目的重點在人工智慧驅動的藥物發現、平台與產品投資模式、不斷進化的併購和合作策略、IPO和私募流動性途徑，以及影響資本配置的監管變化。各節目單元旨在為投資者提供有關市場動態、風險調整回報和可擴展創新策略的清晰見解。透過坦誠的討論、爐邊談話和精心策劃的小組討論，與會者將可探索資本如何分配、創新管道的發展方向以及如何識別長期贏家。除了以投資者為中心的意見交流之外，藉由超過 150 場展覽、11 個科學軌道以及 30 多個國家的全球合作夥伴，以拓寬他們的市場視野。

Preliminary Agenda

Chairperson's Remarks

Morgan Cheatham, MD, Partner, Head of Healthcare & Life Sciences, Breyer Capital

Rana Lonnen, General Partner, Science Capital

William T. Mayo, Senior Vice President, Research Technology, BMS

Leadership at the Cutting Edge: Innovation, Strategy & Biotech’s Next Frontier

Michael Nally, CEO, Generate:Biomedicines

Interviewed By:

Rahul Chaturvedi, Founder & CEO, Clora, Inc.

From Start-Up CEO to Global AI Leader: What the Future of Drug Discovery Tells Us About Tomorrow’s Best Investments

John Chan, Global Head Digital Informatics & AI, Novartis Pharmaceuticals

Interviewed By:

Rana Lonnen, General Partner, Science Capital

PANEL DISCUSSION:

Driving Innovation Together: The New Rules of VC, Pharma & Industry Leader Collaboration

PANEL MODERATOR:

William T. Mayo, Senior Vice President, Research Technology, BMS

PANELISTS:

Sandeep Burugupalli, Head, Data Science & Biopharmaceuticals R&D, AstraZeneca

PANEL DISCUSSION:

Innovation at the Helm: CEO Journeys through Company Building & Market Breakthroughs

PANEL MODERATOR:

Joanne L. Viney, PhD, Co-Founder & President & CEO, Seismic Therapeutic

PANELISTS:

Catherine Sabatos-Peyton, PhD, CEO, Larkspur Biosciences, Inc.

Rachel Humphrey, MD, President and Founding CEO, Normunity

Adam Townsend, CEO, Merida Biosciences

PANEL DISCUSSION:

Funding the Modern Pipeline: Capital Strategy across Biology, Technology, and Informatics

PANEL MODERATOR:

Rebecca Stevenson, Head, Healthcare Investment Banking, Americas, HSBC

PANELISTS:

Luba Greenwood, CEO, Gallop Oncology

Sophie Jones, CFO, Seismic Therapeutic

Stephanie Oestreich, Managing Director, Myeloma Investment Fund of the MMRF

PANEL DISCUSSION:

Discovery to Delivery: Innovation in Life Sciences and the Models that Scale It

PANEL MODERATOR:

Morgan Cheatham, MD, Partner, Head of Healthcare & Life Sciences, Breyer Capital

PANELISTS:

Cris De Luca, Partner, Sanofi Ventures

Bill Fitzgerald, Head, Biotechnology Markets Americas, Google

PANEL DISCUSSION:

The Future of Lab Funding: Building Stronger Pathways between Academia, Capital, and Spinouts

PANEL MODERATOR:

Michael Langer, Co-Founder and Managing Partner, T.Rx Capital


* 活動內容有可能不事先告知作更動及調整。